Journal of Advances in Developmental Research

E-ISSN: 0976-4844     Impact Factor: 9.71

A Widely Indexed Open Access Peer Reviewed Multidisciplinary Bi-monthly Scholarly International Journal

Call for Paper Volume 17 Issue 2 July-December 2026 Submit your research before last 3 days of December to publish your research paper in the issue of July-December.

Incentive-Misaligned Medicine: Medical Authority, Patient Autonomy, and the Structural Economics of Disease Management

Author(s) Dr. Elias Rubenstein
Country United States
Abstract Modern medicine remains indispensable in emergency care, surgery, diagnostics, infectious disease, trauma care, intensive care, and pharmacological disease management. Yet routine healthcare is often organized around disease identification, diagnostic coding, reimbursable procedures, prescription pathways, payer authorization, chronic monitoring, and institutional throughput. This article introduces the concept of incentive-misaligned medicine to describe a structural condition in which the declared goal of patient health is not consistently matched by the operational incentives of clinical practice, reimbursement, pharmaceutical knowledge transfer, payer control, prescription regulation, liability pressure, and medical authority. Drawing on evidence from low-value care, diagnostic overuse, healthspan medicine, pharmaceutical influence, physician payment incentives, utilization management, insurance churn, prescription gatekeeping, defensive medicine, informed consent, second opinions, dentistry, surgery, mental health, and healthspan access barriers, the article identifies four recurring distortions: overuse, underuse, misprioritization, and selective disclosure. The model also applies to cash-pay longevity medicine, direct-to-consumer testing, aggressive supplement markets, unvalidated biomarker panels, and other healthspan-oriented commercial sectors when authority, uncertainty, financial incentives, and patient vulnerability converge without transparent evidence standards. The article proposes a shift from disease-centered care toward autonomy-based and healthspan-oriented medicine grounded in stronger physician education, transparent incentives, alternative disclosure, evidence-based justification of therapeutic access and refusal, independent verification, proportional autonomy, resource realism, and reimbursement models that reward prevention, conservative care, deprescribing, palliative care, and biological resilience.
Keywords Incentive-misaligned medicine, low-value care, medical authority, patient autonomy, proportional autonomy, healthspan medicine, prescription gatekeeping, informed consent, pharmaceutical influence, reimbursement bias, defensive medicine, overuse, underuse, disease management, geroscience, preventive medicine
Field Medical / Pharmacy
Published In Volume 17, Issue 1, January-June 2026
Published On 2026-06-30
DOI https://doi.org/10.71097/IJAIDR.v17.i1.2026
Short DOI https://doi.org/hb9bsc

Share this